HM

Hitesh Madan Goswami

Active Director Director DIN 03556183
DIN 03556183 First appointment Jul 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jul 2011
Shareholding value •••• Premium profile

About Hitesh Madan Goswami

Data last updated:

Hitesh Madan Goswami is a Director at 4Basecare Precision Health Private Limited (since 2024), Director at 4Basecare Onco Solutions Private Limited (since 2020) and Director at 4Basecare Genomics Private Limited (since 2018). The companies operate in Healthcare, E-Commerce and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹17.58 Cr; the largest is 4Basecare Precision Health Private Limited at ₹14.27 Cr (FY 2025). Earlier, Hitesh Madan Goswami was a Director at Biokart India Private Limited (2011–2018) and Director at Bionivid Technology Private Limited (2011–2019).

DIN 03556183
Primary Designation Director
Industry Healthcare
First Appointment 04 Jul 2011
Oldest Company Age 8 yrs
Largest company 4Basecare Precision Health Private Limited · ₹14.27 Cr (FY 2025)
Combined revenue ₹17.58 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Mar 20242024₹14.27 Cr (FY 2025)Active
Director03 Sep 20202020₹3.12 Cr (FY 2025)Active
4Basecare Genomics Private Limited U74999KA2018PTC112818
Director03 May 20182018₹19.4 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biokart India Private Limited U74900KA2011PTC061787
Director22 Dec 20112011₹2.56 Cr (FY 2024)Active
Bionivid Technology Private Limited U72900KA2011PTC059461
Director04 Jul 20112011₹3.26 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
4Basecare Genomics Private Limited
4Basecare Onco Solutions Private Limited
4Basecare Precision Health Private Limited
Biokart India Private Limited
Premium access

Shareholding and investment profile for Hitesh Madan Goswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Madan Goswami

Hitesh Madan Goswami currently holds 3 directorships: 4Basecare Precision Health Private Limited (Director, since 12 Mar 2024, revenue ₹14.27 Cr (FY 2025)); 4Basecare Onco Solutions Private Limited (Director, since 03 Sep 2020, revenue ₹3.12 Cr (FY 2025)); 4Basecare Genomics Private Limited (Director, since 03 May 2018, revenue ₹19.4 Lakh (FY 2024)).

Hitesh Madan Goswami was first appointed on 04 Jul 2011 as Director at Bionivid Technology Private Limited. The most recent appointment on record is 12 Mar 2024 at 4Basecare Precision Health Private Limited.

The 3 current companies of Hitesh Madan Goswami that report revenue have a combined latest revenue of ₹17.58 Cr: 4Basecare Precision Health Private Limited ₹14.27 Cr (FY 2025); 4Basecare Onco Solutions Private Limited ₹3.12 Cr (FY 2025); 4Basecare Genomics Private Limited ₹19.4 Lakh (FY 2024).

Hitesh Madan Goswami held 2 earlier board appointments: Biokart India Private Limited (Director, 22 Dec 2011 to 04 Dec 2018); Bionivid Technology Private Limited (Director, 04 Jul 2011 to 06 May 2019).

The current boards of Hitesh Madan Goswami's companies include Ganapathy Subramaniam (4Basecare Precision Health Private Limited), Kshitij Datta Rishi (4Basecare Precision Health Private Limited), Sherif Mohammed Kottapurath (4Basecare Precision Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available